NYT vs NXTS: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

NYT has stronger fundamentals based on our AI analysis.

NYT
NEW YORK TIMES CO
BUY
72%
Confidence
VS
NXTS
Nexentis Technologies Inc.
STRONG SELL
95%
Confidence

NYT vs NXTS Fundamental Comparison

Metric NYT NXTS
Revenue $2.8B $0.0
Net Income $344.0M $-4.0M
Net Margin 12.2% N/A
ROE 16.9% -25.0%
ROA 11.5% -19.6%
Current Ratio 1.54x 4.19x
Debt/Equity 0.12x 0.00x
EPS $2.09 $-8.61

Green = Better metric | Red = Weaker metric

View Full NYT Analysis →
View Full NXTS Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

NYT vs AAPL NXTS vs MSFT NYT vs GOOGL NXTS vs AMZN

NYT vs NXTS: Frequently Asked Questions

Is NYT or NXTS a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), NYT has stronger fundamentals. NYT is rated BUY (72% confidence) while NXTS is rated STRONG SELL (95% confidence). This is not investment advice.

How does NYT compare to NXTS fundamentally?

NEW YORK TIMES CO has ROE of 16.9% vs Nexentis Technologies Inc.'s -25.0%. Net margins are 12.2% vs N/A respectively.

Which stock pays higher dividends, NYT or NXTS?

NYT has a dividend yield of N/A or no dividend while NXTS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in NYT or NXTS for long term?

For long-term investing, consider that NYT has BUY rating with 72% confidence, while NXTS has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about NYT vs NXTS?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NYT vs NXTS, the AI consensus favors NYT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.